Udapa-Trio 10Tablet ER

Product Description

Udapa-Trio Tablet ER is an extended-release, triple-action antidiabetic medication designed to manage type 2 diabetes mellitus in adults. It combines Dapagliflozin, Metformin, and Sitagliptin, providing a comprehensive approach to blood sugar control. This combination helps eliminate excess glucose through urine, reduce liver glucose production, improve insulin sensitivity, and enhance pancreatic insulin release.

By maintaining stable blood sugar levels, Udapa-Trio Tablet ER reduces the risk of serious diabetes complications, including kidney damage, eye disorders, nerve damage, cardiovascular problems, and limb loss. Used alongside a healthy diet, regular exercise, and weight management, it supports long-term metabolic and cardiovascular health.

Uses of Udapa-Trio Tablet ER

Management of type 2 diabetes mellitus

Lowers high blood sugar levels

Prevents long-term complications of diabetes

Supports cardiovascular and kidney health

Benefits of Udapa-Trio Tablet ER

Provides triple-action glucose control for better blood sugar management

Eliminates excess glucose via urine (Dapagliflozin)

Reduces glucose production in the liver and enhances insulin sensitivity (Metformin)

Increases insulin secretion and decreases liver glucose production (Sitagliptin)

Helps prevent diabetes-related complications, including heart and kidney issues

Supports once-daily dosing with extended-release formulation for consistent control

How to Use Udapa-Trio Tablet ER

Take exactly as prescribed by your doctor

Swallow the tablet whole; do not crush, chew, or break

Can be taken with or without food, preferably at the same time daily

Maintain proper hydration to avoid dehydration

Monitor blood sugar levels regularly

Continue the full course even if blood sugar levels improve

How Udapa-Trio Tablet ER Works

Dapagliflozin: Increases urinary glucose excretion, lowering blood sugar

Metformin: Reduces liver glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity

Sitagliptin: Enhances incretin hormones to stimulate insulin release and suppress liver glucose production

Together, these three mechanisms provide enhanced glycemic control, reducing complications associated with type 2 diabetes.

Possible Side Effects

Common side effects may include:

Nausea, vomiting, diarrhea, or flatulence

Urinary tract or genital fungal infections

Nasopharyngitis (throat and nasal inflammation)

Headache, dizziness, or fatigue

Stuffy nose or sore throat

Most side effects are mild and usually resolve as the body adjusts. Consult your doctor if they persist.

Safety Advice

Alcohol: Consult your doctor; safety is not established.
Pregnancy & Breastfeeding: Use only after consulting a doctor.
Driving: May reduce alertness or cause dizziness; avoid driving if affected.
Kidney: Use with caution; dose adjustments may be necessary.
Liver: Limited data available; consult your doctor before use.

Storage Instructions

Store in a cool, dry place away from direct sunlight

Keep out of reach of children

Product Specifications

Brand Name: Udapa-Trio Tablet ER

Pack Size: 1×10 Tablets

Therapeutic Class: Antidiabetic / Dapagliflozin + Metformin + Sitagliptin

Prescription: Required

One-Line Composition

Composition: Dapagliflozin + Metformin XR + Sitagliptin per tablet

Product Keywords

Udapa-Trio Tablet ER | Udapa-Trio 1×10 | Triple-Action Diabetes Tablet | Dapagliflozin + Metformin + Sitagliptin | Buy Udapa-Trio Online | Udapa-Trio Tablet Uses | Udapa-Trio Tablet Benefits

If you want, I can now create a WordPress-ready HTML version with headings, meta tags, a